ライフサイエンスコーパス: NO

1 s and roots of three L. barbarum varieties ('No.

2 ic Retinopathy Study Research Group - report no.

3 Analysis of nod-1 sectors suggests that NOD plays a cell-autonomous

4 ptome of PGCs lacking PRC2 resembles that of nos-1nos-2 PGCs.

5 y or at the molecular level, and importantly no aberrant protein expression.

6 ond, a simple nonlinear zonal advection with no ad hoc parameterization of the background sea-surface

7 er each scenario of climate change, assuming no adaptation or population changes.

8 yelination and conduction velocity exhibited no adaptations.

9 of the intervention was high and there were no adverse events.

10 00-fold beta1-AR vs beta2-AR selectivity and no agonism.

11 NO also appears to function in a cGMP-independent manner

12 rted into the current surgical workflow with no alterations.

13 No alternative explanation for clinical hemolysis was fo

14 also increased in AMR patients compared with no AMR and healthy subjects.

15 diated dilation (GMD), urinary nitric oxide (NO), and inflammatory markers were measured before and a

16 ent smoker [yes or no], and diabetes [yes or no]), and their associations with individual and primary

17 r events [yes or no], current smoker [yes or no], and diabetes [yes or no]), and their associations w

18 No apparent changes in cellulose were detected by NMR an

19 ce for genetic short root anomaly (SRA) with no apparent defects in crown is close to 1.3%.

20 No apparent temporal or dose-related changes in clinical

21 tating hemorrhagic fever outbreaks for which no approved therapeutic exists.

22 on-years of follow-up (1982-2012), there was no association between risk of hearing loss and hair col

23 There was no association between stent fracture and the primary en

24 In multivariable analysis, no association was found between TRT and overall prostat

25 However, no association was found for antibiotics exposure early

26 No associations between the individual n-3 PUFAs eicosap

27 nal grandmothers smoking in pregnancy showed no associations.

28 In eyes with no baseline MA, presence of SHRM, SHRM, and PED thicknes

29 when compared with saline (5.54, 3.42), had no benefit on the primary outcome (HVLT-R-DR; difference

30 In addition, no binders, carbon additives or current collectors are a

31 binding among CD4(+) and CD8(+) T cells but no binding by B cells.

32 There is no biomarker for diagnosing active tuberculosis in patie

33 ich includes the turnaway-birth and turnaway-no-birth groups).

34 te constant compared to experiments in which no buffer was added.

35 was noted in 1 patient (2%), and there were no cases of corneal opacity.

36 rogression was observed in 122 (15%) joints, no change in 564 (71%), and reversal in 108 (14%).

37 -1.42]; p = 0.77; low-quality evidence), and no change in the duration of mechanical ventilation (mea

38 , 33.3% had a deterioration in QoL, 9.2% had no change, 9.2% had a small improvement, 13.5% had a mod

39 II-Ser5P, the initiating form of RNAPII, but no changes in H3K27me3, at the promoters of affected end

40 synaptic signaling (e.g., GluA1, PRRT2) with no changes in synaptic GABAergic proteins.

41 APPSWE /PS1dE9 mice exposed to EE, however, no changes were detected in neocortex or between Wt anim

42 No cis-trans interconversions and only one case of catal

43 ts with CKD or ESRD with those patients with no CKD/ESRD.

44 ized type of quantum stereodynamics that has no classical analogue or interpretation.

45 To date there is no clear information on the role of VEGF-A in IPF.

46 a trachomatis and Neisseria gonorrhoeae, but no commercial tests are cleared by the U.S. Food and Dru

47 However, to date, there are no commercially available devices able to obtain ultra-w

48 rolled involves the giant protein titin, but no conclusive support for this hypothesis exists.

49 suggests that in Sargassum muticum there is no connection between phyllotaxis and the apical cell di

50 In particular, there is currently no consensus for the band gap and electronic structure o

51 conventional thermal age model, but we find no correlation between DNA fragmentation and sample age

52 th the anti-cod PAV polyclonal antibody, but no correlation with the anti-carp PAV monoclonal antibod

53 ove], previous cardiovascular events [yes or no], current smoker [yes or no], and diabetes [yes or no

54 The results appear reasonable but no data exist to compare with except those from dynamica

55 No deaths occurred in this trial.

56 ene, anthracene, and Dibenzothiophene showed no degradation.

57 soil carbon loss alternating with phases of no detectable loss.

58 th very low silver levels found in blood and no detectable silver measured in the olfactory bulb and

59 llular viability was demonstrated by in-cell NO detection and total nitrite estimation.

60 A recent Cochrane review found no difference in complications, including urinary tract

61 9; adjusted rates 10% vs 6%; P = 0.018), and no difference in discharge destination (P = 0.11).

62 In addition, there was no difference in mean visual outcome of the first versus

63 In a prespecified secondary analysis, no difference in mortality was found (odds ratio, 1.16;

64 equent with WBRT than with SRS and there was no difference in overall survival between the treatment

65 Results No difference in procedure duration was seen overall (P

66 There was no difference in the primary endpoint of day 1 dyspnea r

67 ms (from 58.9% to 69.2%; P<0.001), there was no difference in unadjusted rate of successful cardiover

68 We found no difference in uptake of screening between the active

69 n of clinically significant prostate cancer, no difference was found in the diagnostic performance of

70 There were no differences in allergic disease between LEAP groups.

71 We found no differences in clinical outcomes between MGUS patient

72 No differences in cortisol levels were found.

73 No differences in OS or second neoplasias were observed

74 nt of intestinal inflammation and there were no differences in previously published metabolic markers

75 We found no differences in the mean change at 1 year in the Hypot

76 No differences were detected in estrogen receptor, proge

77 In black-grass, while no direct causative link was established linking viral i

78 3s are specific to eutherian mammals because no direct homologs exist at the syntenic genomic locus i

79 ated colorectal tumor formation while having no discernable effect on small intestinal tumor formatio

80 threat to the world's aging population, yet no disease-modifying therapies are available.

81 There are no disease-modifying therapies for either FTD or NCL, in

82 cipients and those with either persistent or no DM.

83 dinol (SA-2) containing both antioxidant and NO donor functionalities that provide a therapeutic leve

84 found that treatment with the physiological NO donor S-nitrosoglutathione (GSNO) increased the abund

85 of depressed mood in the control group, but no effect in the supplement group [43.85 +/- 18.98 mm vs

86 In contrast, no effect of embryo genotype was seen in concepti from h

87 Our investigations revealed no effect of retinoschisin on Na/K-ATPase-mediated ATP h

88 ity following PA in healthy participants but no effect on attention-related activity.

89 In contrast, GsMTx-4 had no effect on collagen-induced aggregation or on Ca(2+) i

90 creased CYP27B1 mRNA levels in HCEC, but had no effect on CYP27B1 protein levels.

91 Blockade of muscarinic receptors had no effect on evoked dopamine release, suggesting that fe

92 his study show that hepatic ILK deletion has no effect on insulin action in lean mice but sensitizes

93 OD1YFP) or monomeric mutant G85R SOD1YFP had no effect on net ionic currents measured under voltage c

94 Neonatal BCG had no effect on the development of RW before 13 months of a

95 he intensity of co-intervention ranging from no effect with self-monitoring alone (-1.0 mmHg [-3.3, 1

96 Unfortunately, there is no effective pharmacologic approach for treating or prev

97 Lin(-)IELs develop into a lymphoma for which no effective treatment is available.

98 a detrimental neurodegenerative disease with no effective treatments.

99 d understanding of biochar's impacts on soil NO emissions.

100 No enhancers of the APIP promoter were found.

101 Hybrid lipids show no enrichment at the boundary, but decrease the differen

102 has shown great utility in clinical studies, no equivalent tool is available for rodent animal sample

103 Currently, no estimate of MHT prevalence exists for the general US

104 There was no evidence of a threshold in the exposure-response rela

105 had multiplicative predictive effects, with no evidence of an interaction (p = 0.329 and p = 0.291 f

106 INTERPRETATION: No evidence of benefit for ketamine was found although t

107 During late pregnancy, female mice show no evidence of chronic pain whatsoever.

108 There was no evidence of improvement in complete response within 1

109 No evidence of K-ras mutations was observed.

110 d 68 of 160 (42.5%) without a breast pCR had no evidence of residual nodal disease (P < .01).

111 We find no evidence that either MAC or PAC are associated with L

112 In summary, we found no evidence that ERG is an effector of SPOP mutation in

113 There was no evidence that iCST has an effect on cognition or QoL

114 death may diminish the benefit, and there is no evidence to recommend screening in this group.

115 In contest 1 (no experience) and in contest 2 for the experienced anim

116 facilities, ecological sanitation/other, or no facilities).

117 Most had no fever (99%), descending paralysis (93%), no mental st

118 his trial but declined to participate or had no financial coverage for ASCT in a clinical trial and i

119 ic H2 O2 can oxidize l-Arginine (l-Arg) into NO for enhanced gas therapy.

120 intractability of the more realistic models, no formal parameter inference has previously been conduc

121 NO formation from thiols occurs from the reaction of RSN

122 (adjusted odds ratio, 1.9; 95% CI, 1.4-2.6); no functional status markers were improved by long-term

123 )(MeCN)](+), effectively reductively couples NO(g) at RT in methanol (MeOH), giving a structurally ch

124 nonpathologic MR neuroimaging findings (and no GBCA administration), matched for age and sex, were i

125 Currently, there is no generally accepted model to predict outcomes in stabl

126 sitivity for 14 of the drugs, 9 of which had no genomic biomarker.

127 n Medicaid had 198% higher odds of receiving no glaucoma testing compared with whites possessing comm

128 lower relapse risk in the GO arm than in the No-GO arm (26% v 49%; P < .001).

129 occlusive events with tranexamic acid, with no heterogeneity by site of bleeding (p=0.5956).

130 ring immediate antibiotic treatment and with no history of chronic pulmonary disease or use of asthma

131 D4 count of more than 100 cells per muL, and no history of resistance to elvitegravir, emtricitabine,

132 subjects with both AD and CD, and 10 HC with no history of skin disease was analysed using high-throu

133 NOD HSCs were held in their niche by excess expression o

134 linear sorption and outgassing behavior with no-hysteresis over the entire temperature and water acti

135 ulosis (Map) ovine strain (S-type) contained no identifiable glycopeptidolipids or lipopentapeptide (

136 Plasmodium parasitemia had no impact on EVD outcomes.

137 The DYT4 mutation had no impact on microtubule dynamics suggesting a distinct

138 further indication for the roles of ROS and NO in atherosclerosis.

139 There was no increase in vascular occlusive events with tranexamic

140 (hazard ratio, 2.18; 95% CI, 1.90-2.51) but no increased odds of mortality (odd ratio, 1.07; 95% CI,

141 d artificial intelligences learn things that no individual could learn in a lifetime.

142 NO-induced reduction of cellular viability was demonstra

143 However, the no-infection fish dramatically suppressed tapeworm growt

144 The loading concentration had no influence on short-term fluorescein release and pre-c

145 Protein or lipid addition had no influence on the formation and bioaccessibility of SF

146 of the stimulus, but they provided little or no information about orientation independently of locati

147 he point-of-care and at home with minimal or no instrumentation, it is necessary to streamline unit o

148 Predefined subgroup analyses found no interaction with ejection fraction less than 30%, typ

149 No interactions were observed between lead or bone turno

150 There was no interference in protection between the different vacc

151 e fungal infections compared with placebo or no intervention in critically ill patients without neutr

152 No intervention produced significant changes in VO2 peak

153 erations (matched periods during recall when no items came to mind).

154 No known iron complexes are considered photoluminescent

155 ERS-CoV for humans or animals, and there are no large-scale clinical trials for therapies against MER

156 its disposal and contains, at the same time, no less than twenty H-atoms available for either alpha-

157 Because no library preparation is required, the technology permi

158 pathways and in beta-arrestin 2 recruitment, no ligand-independent activity could be measured.

159 d Proteobacteria phyla, we found that potent Nod-like receptor-stimulating bacteria in the upper airw

160 p human specialist professionals in heads-up no-limit Texas hold'em, the leading benchmark and long-s

161 gale represents a feeding ecomorphology with no living analog, and its giant size and high mandibular

162 s, where tiling units arrange with local but no long-range order, remains challenging.

163 dated memory but the retrosplenial cortex is no longer required for retrieval.

164 ectrons to bind electronegative ligands, and no low-lying acceptor orbitals on the central atom.

165 e rate of 86% (95% CI, 83.0% to 88.7%), with no major safety signals.

166 s start to decay immediately, since there is no means to restitute the energy dissipated.

167 (MECP2(T158M/T158M) ), hESC line expressing no MECP2 (MECP2-KO), congenic pair of wild-type and muta

168 no fever (99%), descending paralysis (93%), no mental status change (91%), at least 1 ocular weaknes

169 was defined as a negative symptom report or no mention of a symptom in the EMR for patients who repo

170 promising approach for diabetes reversal in NOD mice.

171 periments using polar solvents, such as DMF, no "mixed" products possessing structurally different am

172 ed that these commonly studied variants were no more associated with the disorder than would be expec

173 ity margin of 4.0% was selected to allow for no more than a clinically negligible 6.0% breakthrough r

174 d the impact of granzyme A deficiency in the NOD mouse model of autoimmune diabetes.

175 17 healthy subjects); 46 fecal samples, but no mucosal samples, were collected and analyzed.

176 d) NO3(-) leachate load from soybean fields (no N fertilizer applied).

177 nalities that provide a therapeutic level of NO necessary to promote angiogenesis and to protect ECs

178 No neutralizing antibodies to evolocumab were detected.

179 Reactions between nitric oxide (NO), nitrite (NO2-), and unsaturated fatty acids give ri

180 Dutch Clinical Trial Registration no: NL30551.068.09.

181 Despite no novel chemical marker has been identified, the (1)H N

182 However, no one method is appropriate to address all biological q

183 Most patients stopped or used no opioids owing to adequate pain control, and 16% to 29

184 h each other in large complexes that contain no other detectable protein subunits.

185 sed early risk of developing AML and CML but no other hematologic malignancies.

186 pulldown assays demonstrated that UL20, but no other HSV-1 gene-encoded proteins, binds specifically

187 Conclusion These data show no overall evidence of improved survival with Cel.

188 sion This study provides evidence to support no overall outcome benefit from adjuvant anthracyclines

189 No participants in the scalp cooling group received anth

190 ed to test effects of agents that target the NO pathway in reducing arterial stiffness in HFpEF.

191 No patient developed an orbital recurrence.

192 No patient had a manic switch or was hospitalized for a

193 No patients from hereditary NS group had NS recurrence a

194 orption properties of a molecular rotor with no permanent voids or channels in its crystal structure.

195 Yet, no pharmacological prevention or specific treatment for

196 SIX-14-Cu-i, exhibited a type V isotherm and no phase change.

197 ) (<2 PIMT/year); and 3) non-compliers (NC) (no PIMT).

198 Analysis of nod-1 sectors suggests that NOD plays a cell-autonomous function in the leaf.

199 s 87.5% (95% CI, 86.5%-88.4%) for women with no pregnancy) (age-adjusted HR, 0.22; 95% CI, 0.10-0.49;

200 symptomatic women with singleton gestations, no previous spontaneous preterm births, and cervical len

201 No previous study of bee spatial navigation has been abl

202 cancer (Gleason pattern 3) who had received no previous treatment were randomly assigned (1:1) to va

203 No probe was identified for AST levels.

204 ced oxidative stress and reduced endothelial NO production is a further indication for the roles of R

205 Reduced NO production under drought conditions in UHb plants was

206 During the treatment-free phase, no progression toward advanced phase CML occurred, and a

207 hey are ubiquitously found in eukaryotes but no prokaryotic homolog has been characterized.

208 There are no proven treatments.

209 To our knowledge, there are no published recommendations on the medical management o

210 r painful burn with blisters vs. practically no reaction, multivariable-adjusted RR = 1.01, 95% CI: 0

211 ed risk of sudden death below the median had no reduction in mortality with the ICD (adjusted ICD HR:

212 0.25-1.01]; p = 0.05; low-quality evidence); no reduction in tolerance of enteral feeds (risk ratio,

213 To date, there is no regenerative treatment available.

214 howed mild (1+) central MR in 1 patient, and no residual MR in the remaining 26 patients with valves

215 In the flat slab portions, no rollback has occurred since their formation at approx

216 Comparing to no RRT use, whereas ammonia reduction with CRRT was sign

217 mall study, no safety events were noted, but no safety conclusions can be drawn.

218 In this small study, no safety events were noted, but no safety conclusions c

219 provide high temporal resolution and require no sample preparation.

220 othesized that a negative family history and no sarcomere mutations represent a nonfamilial subgroup

221 s strongly diminished in the presence of the NO scavenger 2-4-carboxyphenyl-4,4,5,5-tetramethylimidaz

222 icity assays as well as adoptive transfer in NOD/SCID/IL2Rgamma mice were used to assess for pathogen

223 e randomized to undergo either standard PM ("no shave", n = 116) or have additional CSM taken ("shave

224 There was no shift to shorter acyl chain lengths observed, suggest

225 a low barrier for the pseudopericylic [1,3]-NO shift, calculated to be only 8.4 kcal/mol above 21.

226 d variation in 40 of 41 genes comprising the NOD signaling pathway.

227 No significant aging effect was observed in [(18) F]Nife

228 There was no significant association between younger age and risk

229 We observed no significant associations between the highest and lowe

230 We found no significant change in prostate cell proliferation in

231 I, -5.6% to -1.0%], P = .004), but there was no significant change in the combined outcome of death o

232 (P=0.009 for within-group changes), whereas no significant changes occurred within the anakinra 2-we

233 gulants were seen in subgroup analyses, with no significant difference according to the indication fo

234 ; all P<0.01), more signs of congestion, but no significant difference in left ventricular ejection f

235 There was no significant difference in the levels of inhibition of

236 Results There was no significant difference in the size or shape of ablati

237 F alleles or TSLPrs1898671 homozygotes, with no significant difference observed between wildtype and

238 emain uncertain, with estimates ranging from no significant difference to nearly 2 degrees C warmer t

239 No significant difference was seen between the placebo p

240 .26 g/L per year to -1.26 g/L per year), but no significant difference was seen in the rate in early-

241 There were no significant differences between groups in patients' g

242 ily members compared to controls, there were no significant differences in allele frequencies between

243 s treated by a general internist, there were no significant differences in overall 30-day mortality r

244 No significant differences in postoperative anterior cha

245 n the moderate-severe group (p = 0.008); (3) no significant differences in the mean rod-mediated resp

246 No significant differences were found in the moral distr

247 CI, 1.1 to 6.0; P = .03), whereas there was no significant effect of negative microscopic resection

248 t for MYCN amplification or diploidy but had no significant effect on OS.

249 red with breast-conserving therapy, we found no significant improvement in BCSS or OS for women under

250 No significant interactions between the aortic diameter

251 There were no significant interactions of genotypes with calcium su

252 mulation of cytoplasmic MMP-2 over time, but no significant MMP-3 or MMP-8 production was observed.

253 No significant performance differences were revealed amo

254 size of the breast and axillary disease, and no significant residual PET avidity.

255 No significant treatment effects were observed for durat

256 Although no single feature defines EoE, a constellation of compat

257 No single mutation occurred in all four tumors or in all

258 nal representation electoral rules mean that no single party controls a majority of seats in the legi

259 ring equipment installation, indicating that no sources of target compounds were introduced or, that

260 otection strategy is to protect all species, no species, and cases in between.

261 Statin treatment starts at diagnosis, but no statin has been formally evaluated in, or approved fo

262 Our findings indicated no statistically significant associations between either

263 No statistically significant between-group differences w

264 No statistically significant difference in overall survi

265 evidence review done for the guideline found no statistically significant difference in the efficacy

266 ified peripheral afferent neurons, but found no striking differences in gene expression between male

267 No structural homologs or high-resolution structure exis

268 n the gene UBE3B However, to date, there are no studies that have determined the cellular or enzymati

269 To date, no study has investigated whether chronic sleep restrict

270 d patient outcomes in several human cancers, no such advance has been achieved in muscle-invasive bla

271 Moreover, no such study has utilized RNA derived from bacterial bi

272 There is no support for the adaptive coevolution of the Galpha:RG

273 y led to a gain of 0.199 QALYs compared with no surgery at an incremental cost of $30747, yielding an

274 ealism: (1) SimMan (Laerdal) (control group, no surgical anatomy); (2) "synthetic anatomy for surgica

275 INTERPRETATION: We noted no survival benefit in men with metastatic castration-re

276 NO synthetase expression and NO synthesis are linked to altered metabolism, neoplasti

277 NO synthetase expression and NO synthesis are linked to

278 However, the majority of compounds had no systematic change in concentrations during equipment

279 se-related mutations, but there is currently no systematic framework for translating this information

280 of the proteasome inhibitor bortezomib, but no systematic trial has been undertaken to support its u

281 ow examples of such constraints, but we have no systematic understanding about their extent and cause

282 .09), skin tanning ability (for dark tan vs. no tan, multivariable-adjusted RR = 0.98, 95% CI: 0.92,

283 Until now, no technology compatible with use in unrestrained animal

284 There are currently no therapies to directly inhibit hepatic fibrosis.

285 Cell-dependent minimal to no toxicity of Inh2-B1, and its abilities to down-regula

286 There are no treatment options against MERS-CoV for humans or anim

287 No treatment-related death or graft-versus-host disease

288 Currently no treatments exist for preterm infants with diffuse whi

289 in patients with diabetic retinopathy, with no unanticipated safety events.

290 ive decision-making by a group of simple yes/no units revealed in this study suggest that this mechan

291 95% CI 1.13-3.60) to 3.85% (2.37-5.33), with no unusual variation from the adjusted national incidenc

292 and mouth disease in children worldwide but no vaccine is available against CVA6 infections.

293 However no vaccine was able so far to induce bnAbs demanding the

294 Furthermore, there are currently no validated biomarkers that predict which mRCC patients

295 six chloroplast microsatellite loci revealed no variation.

296 developed and printed onto treated PDMS with no visible signs of delamination and geometrically scali

297 No volume effect was seen among late-career or specialty

298 There are no widely accepted prognostic indices for extranodal mar

299 yl radical ([HO2]/[OH]) and increased [NO2]/[NO] with higher levels of RBS and/or RIS.

300 ham Vasculitis Activity Score by week 12 and no worsening in any body system.